RT-PCR
Updated Cepheid SARS-CoV-2, Flu, RSV Test Nabs FDA EUA
The new version of the multiplex test adds a third gene target for SARS-CoV-2 to detect future viral mutations.
The firm expects that next year it will launch the final version of a battery-powered instrument that can perform high-level multiplexing and provide test results in 30 minutes.
The instrument, which is undergoing the FDA clearance process, has the capability to do PCR testing, clinical chemistry, and immunoassays.
AMP Cautions Against Using Cycle Threshold Values for PCR SARS-CoV-2 Tests in Clinical Practice
Although a cycle threshold value may help determine patient prognosis and risk of transmission, there is limited data on making clinical decisions based on Ct values, AMP said.
ACMG Presentation Highlights Broad Institute's Massive Expansion of COVID-19 Testing Program
The Broad's clinical research sequencing lab now runs 135,000 tests each day and routinely tests more than 100 higher education sites and 40 schools in the state.